Effect of HER2 expression status on the prognosis of patients with HR(+)/HER2(‑) advanced breast cancer undergoing advanced first‑line endocrine therapy

The present study aimed to retrospectively assess the effects of human epidermal growth factor receptor 2 (HER2) expression on the diagnosis of patients with hormone receptor (HR)(+)/HER2(−) late-stage breast cancer undergoing advanced first-line endocrine-based treatment. A total of 72 late-stage b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kan, Du, Qinglei, Yu, Jie, Li, Yao, Zhu, Xulong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265361/
https://www.ncbi.nlm.nih.gov/pubmed/37323815
http://dx.doi.org/10.3892/ol.2023.13885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265361/
https://www.ncbi.nlm.nih.gov/pubmed/37323815
http://dx.doi.org/10.3892/ol.2023.13885

Ejemplares similares